Facebook
Twitter
LinkedIn
ForwardWisconsin Association of Hematology and Oncology (WAHO) Annual Conference - September 24, 2022
Target Audience
Physicians, Pharmacists, Physician Assistants, Nurses, and Nurse Practitioners who are interested in the field of Oncology
Learning Objectives
At the end of this educational activity, participants should be able to:
- Summarize recent advances in diagnosing and treating various cancers, including gastrointestinal, lung, and genitourinary cancers.
- Use new knowledge about precision medicine, including the use of immunotherapy and biomarker testing, to inform decisions related to the treatment of some cancers.
- Describe the use of patient-centered dosing to personalize cancer treatment to meet the goals and priorities of each patient.
- Detail state and federal policies affecting the practice of oncology.
- Explain why strengthening their work-life balance is essential for reducing their risk for burnout.
- Discuss the role of health disparities in cancer care.
Physicians: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and the Wisconsin Association of Hematology and Oncology.
Boston University School of Medicine designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity has been provided by Boston University School of Medicine Continuing Nursing Education and jointly provided by the Wisconsin Association of Hematology and Oncology.
Contact Hours: 5.25, of which 1.80 is pharmacology credit worthy
Available Credit
- 5.25 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 5.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 5.25 ANCCBoston University Chobanian & Avedisian School of Medicine, Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
- 1.80 ANCC Pharmacology
- 5.25 ParticipationBoston University Chobanian & Avedisian School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.